drugset / Trial / NCT01298011
Study of Gemcitabine and Abraxane to Treat Potentially Operable Pancreatic Cancer
NaSingle-groupOpen-labelTreatment
Summary
The main purpose of this research study is to evaluate whether Abraxane and gemcitabine are effective in treating patients with operable pancreatic cancer.
Timeline
- Start
- 2011-05
- Primary completion
- 2013-12
- Completion
- 2015-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gemcitabine | Small molecule | — | — |
| Subject | Nab-paclitaxel | Small molecule | — | — |